WO1999045105A3 - Highly crystalline urokinase - Google Patents

Highly crystalline urokinase Download PDF

Info

Publication number
WO1999045105A3
WO1999045105A3 PCT/US1999/004992 US9904992W WO9945105A3 WO 1999045105 A3 WO1999045105 A3 WO 1999045105A3 US 9904992 W US9904992 W US 9904992W WO 9945105 A3 WO9945105 A3 WO 9945105A3
Authority
WO
WIPO (PCT)
Prior art keywords
urokinase
highly crystalline
modified urokinase
modified
polynucleotides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1999/004992
Other languages
French (fr)
Other versions
WO1999045105A2 (en
Inventor
Jieyi Wang
Vicki L Nienaber
Jack Henkin
Richard A Smith
Karl A Walter
Jean M Severin
Rohinton Edalji
Robert W Johnson Jr
Thomas Holzman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Priority to JP2000534637A priority Critical patent/JP2003521222A/en
Priority to EP99909895A priority patent/EP1060255A2/en
Priority to CA002322622A priority patent/CA2322622A1/en
Priority claimed from US09/264,468 external-priority patent/US20020106775A1/en
Publication of WO1999045105A2 publication Critical patent/WO1999045105A2/en
Publication of WO1999045105A3 publication Critical patent/WO1999045105A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6462—Plasminogen activators u-Plasminogen activator (3.4.21.73), i.e. urokinase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21073—Serine endopeptidases (3.4.21) u-Plasminogen activator (3.4.21.73), i.e. urokinase

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

The present disclosure describes a biologically active modified urokinase and high resolution crystalline forms of modified urokinase. Polynucleotides which encode modified urokinase and methods for making modified urokinase are also disclosed.
PCT/US1999/004992 1998-03-06 1999-03-05 Highly crystalline urokinase Ceased WO1999045105A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2000534637A JP2003521222A (en) 1998-03-06 1999-03-05 Highly crystalline urokinase
EP99909895A EP1060255A2 (en) 1998-03-06 1999-03-05 Highly crystalline urokinase
CA002322622A CA2322622A1 (en) 1998-03-06 1999-03-05 Highly crystalline urokinase

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US3636198A 1998-03-06 1998-03-06
US09/036,361 1998-03-06
US09/264,468 1999-03-05
US09/264,468 US20020106775A1 (en) 1999-03-05 1999-03-05 Highly crystalline urokinase

Publications (2)

Publication Number Publication Date
WO1999045105A2 WO1999045105A2 (en) 1999-09-10
WO1999045105A3 true WO1999045105A3 (en) 2000-03-09

Family

ID=26713110

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/004992 Ceased WO1999045105A2 (en) 1998-03-06 1999-03-05 Highly crystalline urokinase

Country Status (4)

Country Link
EP (1) EP1060255A2 (en)
JP (1) JP2003521222A (en)
CA (1) CA2322622A1 (en)
WO (1) WO1999045105A2 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0338409A1 (en) * 1988-04-18 1989-10-25 PHARMACIA S.p.A. Low molecular weight derivatives of prourokinase and pharmaceutical compositions containing the same
EP0496327A1 (en) * 1991-01-22 1992-07-29 Grünenthal GmbH Polypeptides with prourokinase activity, plasmids coding therefor and process for their preparation and use

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0338409A1 (en) * 1988-04-18 1989-10-25 PHARMACIA S.p.A. Low molecular weight derivatives of prourokinase and pharmaceutical compositions containing the same
EP0496327A1 (en) * 1991-01-22 1992-07-29 Grünenthal GmbH Polypeptides with prourokinase activity, plasmids coding therefor and process for their preparation and use

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
LIJNEN, H.R. ET AL.: "Biochemical properties of recombinant single-chain urokinase-type plasminogen activator mutants with deletion of Asn2 through Phe157 and/or substitution of Cys279 with Ala", EUROPEAN JOURNAL OF BIOCHEMISTRY, vol. 205, no. 2, 15 April 1992 (1992-04-15), pages 701 - 709, XP002126807 *
SPRAGGON, G. ET AL.: "The crystal structure of the catalytic domain of human urokinase-type plasminogen activator", STRUCTURE, vol. 3, no. 7, 15 July 1995 (1995-07-15), pages 681 - 691, XP002126808 *

Also Published As

Publication number Publication date
EP1060255A2 (en) 2000-12-20
WO1999045105A2 (en) 1999-09-10
CA2322622A1 (en) 1999-09-10
JP2003521222A (en) 2003-07-15

Similar Documents

Publication Publication Date Title
WO2001079461A3 (en) Polypeptides having haloperoxidase activity
ZA977948B (en) Process for the control of weeds.
WO2001079458A3 (en) Polypeptides having haloperoxidase activity
WO2001079459A3 (en) Polypeptides having haloperoxidase activity
AU2717999A (en) Process for the production of gamma-butyrolactone
AU5812199A (en) Plant farnesyltransferases
AU6246599A (en) Method of producing permuteins by scanning permutagenesis
AU2515399A (en) Process for the production of gamma-butyrolactone
WO2000022019A3 (en) Coupled block copolymers and process for producing the block copolymers
AU6780298A (en) Production of 1,3-diaminopentane by hydrogenation of 3-aminopentanenitrile
AU7517694A (en) Synthesis of 4,10-dinitro-2,6,8,12-tetraoxa-4,10-diazatetracyclo(5.5.0.05 ,9-03,11-)dodecane
AUPP715098A0 (en) Cultivator point assembly
KR20010006560A (en) Tunneling Plant
AU2851899A (en) Method for producing 2,2'-dihydroxybiphenyls
WO1999045105A3 (en) Highly crystalline urokinase
AU7017398A (en) Plant for manufacturing gas by electrolysis
AU8437998A (en) Method for producing 4,4' dihalogendiphenylsulfone
AU5214300A (en) Method for producing 2,2,4,4-tetra-substituted 1,3,5-cyclohexanetriones
AU6837198A (en) Improving the preservability of plants
AU3446799A (en) Process plant
AU3932599A (en) Method for producing shaped bodies
AU4917599A (en) Plant dwarfing
AU4186999A (en) Crowne zoysiagrass plant
AU3139999A (en) Method for the production of 1,3-disubstituted 2-nitroguanidines
ID16030A (en) PROCESS OF MAKING 1.5-BENZOTIAZEPIN DOWN

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): CA JP MX

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): CA JP MX

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

WWE Wipo information: entry into national phase

Ref document number: 1999909895

Country of ref document: EP

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2000 534637

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: PA/a/2000/008695

Country of ref document: MX

ENP Entry into the national phase

Ref document number: 2322622

Country of ref document: CA

Ref country code: CA

Ref document number: 2322622

Kind code of ref document: A

Format of ref document f/p: F

WWP Wipo information: published in national office

Ref document number: 1999909895

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1999909895

Country of ref document: EP